Effect of iron depletion on long-term response to interferon-α in patients with chronic hepatitis C who previously did not respond to interferon therapy

American Journal of Gastroenterology

Volumn 92, Issue 10, 1997, Pages 1831-1834

  Tsai, Naoky C S ^b   Zuckerman, Eli ^b   Han, Steven H ^b   Goad, Kimberly ^b   Redeker, Allan G ^b   Fong, Tse Ling ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; IRON DEFICIENCY; IRON STORAGE; MALE; PHLEBOTOMY; PRIORITY JOURNAL;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; IRON; MALE; MIDDLE AGED; PHLEBOTOMY; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0030774786     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
2. Pockros PJ, Tong MJ, Lee WM, et al. Relationship between biochemical and virological response to Type 1 interferon therapy of chronic HCV infection. Hepatology 1996;24:155A.
3. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
4. Van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon α therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-15.
5. Arber N, Moshkowitz M, Konikoff F, et al. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection. Dig Dis Sci 1995;40:2431-3.
6. Girelli CM, Mirata C, Lesinigo E, et al. Iron overload and response to α-interferon in chronic hepatitis C. Am J Gastroenterol 1995;90: 170-1.
7. Barton AL, Banner BF, Cable EE, et al. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 1995;103:419-24.
8. Hayashi H, Takikawa T, Nishimura N, et al. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic hepatitis, active hepatitis C, and excess hepatic iron. Am J Gastroenterol 1994;89:986-8.
9. Bacon BR, Rebholz AE, Fried MW, et al. Beneficial effect of iron reduction therapy in patients with chronic hepatitis C who failed to respond to interferon-α. Hepatology 1993;18:150A (abstract).
10. Han S-H, Fong T-L, Valinluck B, et al. Randomized controlled trial of , the effect of iron depletion on aminotransferase levels, HCV RNA, and response to interferon therapy in patients with chronic hepatitis C virus. Hepatology 1995;22:180A (abstract).
11. Davis GL, Lau IY-K, Urdea MS, et al. Quantitative detection of hepatitis C viral RNA with a solid phase signal amplification method: Definition of optimal conditions for specimen collection and clinical amplification in interferon treated patients. Hepatology 1994;19:1337-41.
12. Cristiano K, Di Bisceglie AM, Hoofnagle JH, et al. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: Detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991;14:51-5.
13. Ohno T, Mitzokami M. Wu R-R, et al. A new hepatitis C genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiology 1997;35:201-7.
14. Morgan EH. Iron metabolism and transport. In: Zakim D, Boyer TD, eds. Hepatology. A textbook of liver disease. Philadelphia: WB Saunders, 1996:526-53.
15. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102:2108-13.
16. Han S-H, Tsai N, Morgan TR, et al. A pilot randomized controlled trial of the effect of iron depletion on long term response to α-interferon in patients with chronic hepatitis C virus. Hepatology 1996;24:405A (abstract).
17. Brillanti S, Garson J, Foli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994;107:812-7.
18. Marcellin P, Pouteau M, Boyer N, et al. Retreatment with recombinant interferon-α in patients with chronic hepatitis C. J Infect Dis 1993; 167:780-1.
19. Herrera JL. Effects of phlebotomy in patients with chronic hepatitis C who failed to respond to a prior course of intereron α-2b. Hepatology 1996;24:404A (abstract).
20. Pouteau M, Courtois F, Martinet M, et al. Effects of phlebotomy in patients with chronic hepatitis C nonresponders to interferon therapy. Hepatology 1996;24:404A (abstract).
21. Guvader D, Boucher E, Even C, et al. Iron reduction therapy is inefficient in patients with chronic hepatitis C who failed to respond to interferon. Hepatology 1996;24:405A (abstract).